Post licensure surveillance of Human Papillomavirus vaccine, vaccine adverse event reporting system, 2010-2017
Currently, there are three approved and commercially available Human Papillomavirus (HPV) vaccines. These are Gardasil®, a quadrivalent HPV, Cervarix®, a bivalent vaccine, and Gardasil®9, a nonvalent HPV and they were first approved in 2006, 2009, and 2014, respectively for use in females. Approvals...
| Main Author: | |
|---|---|
| Format: | Thesis (University of Nottingham only) |
| Language: | English |
| Published: |
2022
|
| Subjects: | |
| Online Access: | https://eprints.nottingham.ac.uk/69495/ |